A detailed history of Bard Financial Services, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bard Financial Services, Inc. holds 2,670 shares of LLY stock, worth $2.12 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
2,670
Previous 1,870 42.78%
Holding current value
$2.12 Million
Previous $1.66 Million 42.81%
% of portfolio
0.28%
Previous 0.35%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$772.14 - $960.02 $617,712 - $768,016
800 Added 42.78%
2,670 $2.37 Million
Q3 2024

Oct 04, 2024

SELL
$772.14 - $960.02 $2.9 Million - $3.6 Million
-3,750 Reduced 66.73%
1,870 $1.66 Million
Q2 2024

Jul 09, 2024

SELL
$724.87 - $909.04 $90,608 - $113,630
-125 Reduced 2.18%
5,620 $5.09 Million
Q1 2024

May 06, 2024

SELL
$592.2 - $792.28 $145,089 - $194,108
-245 Reduced 4.09%
5,745 $4.47 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $99,786 - $117,634
190 Added 3.28%
5,990 $3.49 Million
Q3 2023

Oct 16, 2023

BUY
$434.7 - $599.3 $21,735 - $29,964
50 Added 0.87%
5,800 $3.12 Million
Q2 2023

Jul 11, 2023

BUY
$350.74 - $468.98 $35,074 - $46,898
100 Added 1.77%
5,750 $2.7 Million
Q1 2023

Apr 26, 2023

BUY
$310.63 - $364.82 $38,828 - $45,602
125 Added 2.26%
5,650 $1.94 Million
Q4 2022

Jan 25, 2023

BUY
$321.55 - $374.67 $273,317 - $318,469
850 Added 18.18%
5,525 $2.02 Million
Q3 2022

Oct 26, 2022

BUY
$296.48 - $337.87 $99,320 - $113,186
335 Added 7.72%
4,675 $1.51 Million
Q2 2022

Jul 06, 2022

BUY
$278.73 - $327.27 $34,841 - $40,908
125 Added 2.97%
4,340 $1.41 Million
Q4 2020

Mar 26, 2021

BUY
$130.46 - $172.63 $549,888 - $727,635
4,215 New
4,215 $712,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bard Financial Services, Inc. Portfolio

Follow Bard Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bard Financial Services, Inc. with notifications on news.